Sichuan Kelun Pharmaceutical Co (SZSE:002422) Long-Term Capital Lease Obligation : ¥257 Mil (As of Mar. 2024)

View and export this data going back to 2010. Start your Free Trial

What is Sichuan Kelun Pharmaceutical Co Long-Term Capital Lease Obligation?

Sichuan Kelun Pharmaceutical Co's Long-Term Capital Lease Obligation for the quarter that ended in Mar. 2024 was ¥257 Mil.

Sichuan Kelun Pharmaceutical Co's quarterly Long-Term Capital Lease Obligation increased from Sep. 2023 (¥232 Mil) to Dec. 2023 (¥245 Mil) and increased from Dec. 2023 (¥245 Mil) to Mar. 2024 (¥257 Mil).

Sichuan Kelun Pharmaceutical Co's annual Long-Term Capital Lease Obligation increased from Dec. 2021 (¥16 Mil) to Dec. 2022 (¥52 Mil) and increased from Dec. 2022 (¥52 Mil) to Dec. 2023 (¥245 Mil).

Sichuan Kelun Pharmaceutical Co Long-Term Capital Lease Obligation Historical Data

The historical data trend for Sichuan Kelun Pharmaceutical Co's Long-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sichuan Kelun Pharmaceutical Co Long-Term Capital Lease Obligation Chart

Sichuan Kelun Pharmaceutical Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Long-Term Capital Lease Obligation

Get a 7-Day Free Trial

18.41

16.18

51.74

245.23

Sichuan Kelun Pharmaceutical Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Long-Term Capital Lease Obligation	Get a 7-Day Free Trial															249.39	235.69	232.16	245.23	256.77

Sichuan Kelun Pharmaceutical Co (SZSE:002422) Long-Term Capital Lease Obligation Explanation

Long-Term Capital Lease Obligation are the amount due for long-term asset lease agreements that are nearly equivalent to asset purchases. Capital lease obligations are installment payments that constitute a payment of principal plus interest for the capital lease. The Short-Term Capital Lease Obligation is the portion of a Long-Term Capital Lease Obligation that is due over the next year.

Under US Generally Accepted Accounting Principles (GAAP), a capital lease is essentially equivalent to a purchase by the lessee if it meets the following criteria:

1. Ownership of the asset is transferred to the lessee at the end of the lease term;
2. The lease contains a bargain purchase option to buy the equipment at less than fair market value;
3. The lease term equals or exceeds 75% of the asset's estimated useful life;
4. The present value of the lease payments equals or exceeds 90% of the total original cost of the equipment.

Sichuan Kelun Pharmaceutical Co Long-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Sichuan Kelun Pharmaceutical Co's Long-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Sichuan Kelun Pharmaceutical Co (SZSE:002422) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sichuan Kelun Pharmaceutical Co Ltd (SZSE:002422) » Definitions » Long-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

N/A

Address

No.36 West Baihua Road, Qingyang District, Chengdu, CHN, 610071

Website

http://www.kelun.com

Sichuan Kelun Pharmaceutical Co Ltd is a China-based Pharmaceutical company mainly focused on the production and sales of injection products, including products for glucose injection and sodium chloride injection. It manufactures and sells high-volume injections (infusions), small-volume injections (water needles), sterile powder injections (containing powdered and freeze-dried powder). Its products include tablets, capsules, capsules, granules, oral liquids, peritoneal dialysis fluids, raw material medicines, medical packaging materials, medical instruments, and antibiotic intermediates.

Executives

Lai De Gui	Executives
Feng Hao	Directors, executives
Liu Si Chuan	Directors, executives
Wang Jing Yi	Directors, executives
Wan Yang Yu	Executives
Ge Jun You	Executives
Wu Zhong Hua	Executives
Wan Peng	Supervisors
Tan Hong Bo	Executives
Liu Ge Xin	Director
Huang Xin	Securities Affairs Representative
Ge Tao	Executives
Pan Hui	Directors, executives
Zhou Xiao Dong	Executives
Zheng Chang Yan	Supervisors

Sichuan Kelun Pharmaceutical Co (SZSE:002422) Headlines

No Headlines